Drug Research
US FDA approves Janssen’s PONVORY for relapsing multiple sclerosis
The US FDA has approved the Janssen Pharmaceutical Companies of Johnson & Johnson’s (JNJ) PONVORY (ponesimod) for treating adults with relapsing forms of multiple sclerosis (MS).
PONVORY is a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator. The approval will...
Drug Research
Gilead and Novo Nordisk Expand NASH Clinical Collaboration
Gilead Sciences, Inc. and Novo Nordisk A/S announced that the companies have expanded their clinical collaboration in non-alcoholic steatohepatitis (NASH).
The companies will conduct a Phase 2b double-blind, placebo-controlled study to investigate the safety and efficacy of Novo Nordisk’s semaglutide,...
Drug Research
Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy
Tevogen Bio has entered a partnership with BioCentriq, a New Jersey based cell and gene therapy development and manufacturing center, to support clinical manufacturing of Tevogen’s investigational COVID-19 treatment.
Both partners will collaborate at BioCentriq’s state-of-the art GMP facilities to...
Drug Research
Insilicos Chemistry42 AI system integrated into UCBs drug discovery programs
Insilico Medicine, an AI drug discovery company, announced that UCB will integrate Insilico's Chemistry42â„¢ into UCB's internal drug discovery pipeline. UCB's early adoption of Insilico Medicine's proprietary technology will provide UCB's scientists with the ability to design novel hit...
Drug Research
PsiVac and Lonza Enter a Strategic Agreement for the Process Development and cGMP Manufacturing of Ixovex-1
PsiVac, a subsidiary of Ixogen; a UK biotechnology research and development company focused on the development of new therapeutic cancer treatments for solid tumors, and Lonza, a world leader in contract manufacturing, announced their agreement for the process development...
Drug Research
Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a supply agreement with the Government of The Philippines for 13 million doses of the COVID-19 Vaccine Moderna.
Under the terms of this agreement, deliveries would begin...
Drug Research
AGC Biologics Announces the Expansion of Their Cell and Gene Therapy Facility in Milan, Italy
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced plans for the expansion of their Cell and Gene Therapy Center of Excellence in Milan, to increase capacities and implement viral vector suspension capabilities.
With this expansion,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read